• Cynomolgus TNFRSF17/BCMA/CD269 protein (Recombinant) (C-hFc) (STJP002015)
  • Cynomolgus TNFRSF17/BCMA/CD269 protein (Recombinant) (C-hFc) (STJP002015)
  • Cynomolgus TNFRSF17/BCMA/CD269 protein (Recombinant) (C-hFc) (STJP002015)
  • Cynomolgus TNFRSF17/BCMA/CD269 protein (Recombinant) (C-hFc) (STJP002015)

Cynomolgus TNFRSF17/BCMA/CD269 protein (Recombinant) (C-hFc) (STJP002015)

SKU:
STJP002015-100

Shipping:
Free Shipping
Current Stock:
Host: HEK293 cells
Reactivity: Cynomolgus
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Recombinant-Cynomolgus TNFRSF17/BCMA/CD269-C-hFc protein was developed from hek293 cells and has a target region of C-hFc. For use in research applications.
Formulation: Lyophilized from a 0.2 Mu m filtered solution of PBS, pH 7.4.
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Immunogen Region: Met1-Ala53
Immunogen: Recombinant Human Angiopoietin-2/ANGPT2 Protein is produced by mammalian expression system. The target protein is expressed with sequence (Met1-Ala53) of cynomolgus BCMA (Accession #G7Q0I4) fused with an Fc tag at the C-terminus.
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance